Background: Bipolar disorder (BD) patients have cognitive deficits that may remain in the euthymic phase. Similar although milder cognitive deficits may be found in their first-degree relatives. We wanted to analyze whether the self-report of seasonality, the season when individuals were tested or the circadian preference influences the neuropsychological test performance measured in the familial BD, type I, patients and their healthy first-degree relatives.

Method: A structured diagnostic interview (SCID) and neuropsychological test battery were administered to 32 familial BD type I patients, 40 of their unaffected first-degree relatives and 50 controls, all from population-based samples. BD patients and their relatives filled in the Seasonal Pattern Assessment Questionnaire (SPAQ) and the Horne-Östberg Morningness-Eveningness Questionnaire (MEQ).

Results: Individuals, who reported that seasonal variation was a problem, scored worse on the measures of visuoconstructional functions, visuospatial reasoning, auditory attention and working memory, and verbal memory than those with no seasonal variation. The season when tested had an influence on test performance. Individuals from the families that were tested in spring, summer and autumn scored better than those tested in winter on the measures of visual and verbal attention, working memory, verbal ability, verbal fluency, and executive functioning. Among the controls there was no difference in the test scores from season to season. The circadian preference had no effect on test performance.

Limitations: Only relatives, not BD patients were tested in winter.

Conclusion: Seasonal variation in mood and behavior as a problem in patients and their first-degree relatives influences negatively the neuropsychological test performance. In addition, among the patients and first-degree relatives the neuropsychological test performance in winter may be worse than in other seasons.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2010.04.021DOI Listing

Publication Analysis

Top Keywords

neuropsychological test
20
test performance
20
first-degree relatives
20
seasonal variation
16
test
8
patients
8
bipolar disorder
8
cognitive deficits
8
circadian preference
8
familial type
8

Similar Publications

Cerebral perfusion correlates with amyloid deposition in patients with mild cognitive impairment due to Alzheimer's disease.

J Prev Alzheimers Dis

February 2025

Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China, 154 Anshan Road Tianjin 300052, PR China; Department of Neurology, Tianjin Medical University General Hospital Airport Site, Tianjin 300052, PR China. Electronic address:

Background: Changes in cerebral blood flow (CBF) may contribute to the initial stages of the pathophysiological process in patients with Alzheimer's disease (AD). Hypoperfusion has been observed in several brain regions in patients with mild cognitive impairment (MCI). However, the clinical significance of CBF changes in the early stages of AD is currently unclear.

View Article and Find Full Text PDF

Background: Cognitive training (CT) has been one of the important non-pharmaceutical interventions that could delay cognitive decline. Currently, no definite CT methods are available. Furthermore, little attention has been paid to the effect of CT on mood and instrumental activities of daily living (IADL).

View Article and Find Full Text PDF

High definition transcranial direct current stimulation as an intervention for cognitive deficits in Alzheimer's dementia: A randomized controlled trial.

J Prev Alzheimers Dis

February 2025

Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA; School of Behavioral and Brain Sciences, University of Texas at Dallas, Dallas, TX, USA.

Background: Recent disease-modifying treatments for Alzheimer's disease show promise to slow cognitive decline, but show no efficacy towards reducing symptoms already manifested.

Objectives: To investigate the efficacy of a novel noninvasive brain stimulation technique in modulating cognitive functioning in Alzheimer's dementia (AD).

Design: Pilot, randomized, double-blind, parallel, sham-controlled study SETTING: Clinical research site at UT Southwestern Medical Center PARTICIPANTS: Twenty-five participants with clinical diagnoses of AD were enrolled from cognition specialty clinics.

View Article and Find Full Text PDF

Background: A mobile cognition scale for community screening in cognitive impairment with rigorous validation is in paucity. We aimed to develop a digital scale that overcame low education for community screening for mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and AD.

Methods: A mobile cognitive self-assessment scale (CogSAS) was designed through the Delphi process, which is feasible for the older population with low education.

View Article and Find Full Text PDF

Cognitive impairment in patients with COVID-19 has been reported, but findings are inconsistent. This study assessed cognitive functioning 6 months post-infection across three COVID-19 severity groups compared to non-COVID controls. Seventy-two ICU-treated, 49 ward-treated, and 44 home-isolated patients with COVID-19, along with 48 controls, underwent neuropsychological evaluation and assessment of subjective cognitive symptoms, depressive symptoms, and fatigue.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!